BRIEF published on 02/03/2025 at 14:05, 10 months 1 day ago 01 Communique Enters Market Making Agreement with Integral Wealth TSX Venture Exchange Cybersecurity Market Making 01 Communique Integral Wealth
PRESS RELEASE published on 02/03/2025 at 14:00, 10 months 1 day ago 01 Communique Announces a Market Making Agreement with Integral Wealth 01 Communique partners with Integral Wealth Securities for market making agreement to enhance liquidity of common shares in quantum era cybersecurity sector Liquidity Cybersecurity 01 Communique Integral Wealth Securities Market Making Agreement
BRIEF published on 01/23/2025 at 14:05, 10 months 12 days ago 01 Communique Strengthens Financials and Updates Quantum-Safe Initiatives Financial Results Cybersecurity Strategic Partnership Quantum Computing PQC Technology
PRESS RELEASE published on 01/23/2025 at 14:00, 10 months 12 days ago 01 Communique Provides Update on Business Developments and Fourth Quarter and Fiscal 2024 Results 01 Communique strengthened its balance sheet with post year-end financing, reporting fourth quarter and fiscal 2024 results. Company focuses on cybersecurity for quantum computing era Cybersecurity Balance Sheet Quantum Computing 01 Communique Post Year-end Financing
BRIEF published on 01/21/2025 at 14:05, 10 months 14 days ago 01 Communique Partners with Real Matter for Quantum-Safe Blockchain Solutions Cybersecurity Quantum Computing Blockchain Solutions Post-Quantum Cryptography Fintech Partnership
PRESS RELEASE published on 01/21/2025 at 14:00, 10 months 14 days ago 01 Communique Announces Partnership with Real Matter 01 Communique Lab Inc. partners with Real Matter to integrate IronCAP PQC technology for quantum-safe blockchain solutions. Collaboration aims at driving Quantum readiness in key sectors 01 Communique IronCAP Real Matter PQC Technology Quantum-safe Blockchain
BRIEF published on 01/20/2025 at 14:05, 10 months 15 days ago 01 Communique to Announce Q4 2024 Results and Hold Conference Call Conference Call Cybersecurity 01 Communique IronCAP Q4 2024 Results
PRESS RELEASE published on 01/20/2025 at 14:00, 10 months 15 days ago 01 Communique to Report Fourth Quarter 2024 Results and Host a Conference Call on Thursday January 23, 2025 01 Communique Laboratory Inc. to release Q4 2024 financial results on Jan 23, 2025, focusing on IronCAP™ cybersecurity products. Live update at 10:00AM EST Technology 01 Communique Laboratory Inc. Q4 2024 Financial Results IronCAP™ Cybersecurity Live Update
BRIEF published on 01/07/2025 at 22:05, 10 months 28 days ago 01 Communique Completes Non-brokered Private Placement Private Placement Technology Cybersecurity Investment Quantum Computing
PRESS RELEASE published on 01/07/2025 at 22:00, 10 months 28 days ago 01 Communique Announces Completion of Non-brokered Private Placement 01 Communique Laboratory Inc. closes private placement with strategic investors for quantum cybersecurity. Funds to fuel product development and growth Private Placement 01 Communique Laboratory Inc. Strategic Investors Product Development Quantum Cybersecurity
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 35 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 40 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 50 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 55 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 21 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
